Search Results 201-210 of 1749 for ���������������������katalk:po03���������������������,������������������,������������������,������������������
This phase II trial studies how well temsirolimus and bevacizumab work in treating patients with advanced endometrial, ovarian, liver, carcinoid, or islet cell ...
A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of ...
This study will assess the efficacy and outcomes of PD-1 blockade in patients with mismatch repair deficient colorectal cancer. Participation eligibility.
Nivolumab works through the body's immune system to help the immune system act against tumor cells. Chemotherapy drugs, such as paclitaxel, work in different ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Talk to a member of your health care team before you stop taking any medications in order to donate blood. Wear a shirt with sleeves that can be rolled up ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.